US2018326136A1PendingUtilityA1
Phosphate adsorbing agent for blood processing, blood processing system and blood processing method
Assignee: ASAHI KASEI MEDICAL CO LTDPriority: Nov 11, 2015Filed: Nov 11, 2016Published: Nov 15, 2018
Est. expiryNov 11, 2035(~9.3 yrs left)· nominal 20-yr term from priority
B01J 20/28004B01J 20/28061B01D 15/00B01J 20/28085A61M 1/3687B01J 20/28059B01D 71/58B01J 20/0211B01D 71/68A61M 1/1621B01J 20/06B01J 20/26B01J 20/28B01J 2220/46B01J 20/10B01J 20/08A61M 1/36A61M 1/16
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a phosphate adsorbing agent for blood processing comprising a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having the most frequent pore size of 0.08 to 0.70 μm measured with a mercury porosimeter. The present invention also relates to a blood processing system and a blood processing method involving the phosphate adsorbing agent for blood processing.
Claims
exact text as granted — not AI-modified1 . A phosphate adsorbing agent for blood processing comprising a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having the most frequent pore size of 0.08 to 0.70 μm measured with a mercury porosimeter.
2 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein an outer surface opening ratio of the porous formed article is 5% or more and less than 30%.
3 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein a specific surface area measured with a mercury porosimeter, of the porous formed article is 10 to 100 m 2 /cm 3 .
4 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein a ratio of the most frequent pore size of a median size (the most frequent pore size/median size) measured with a mercury porosimeter, of the porous formed article is 0.80 to 1.30.
5 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein the porous formed article is spherical particles having an average particle size of 100 to 2500 μm.
6 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein the inorganic ion adsorbent contains at least one metal oxide represented by the following formula (I):
MN x O n .m H 2 O (I)
wherein x is 0 to 3, n is 1 to 4, m is 0 to 6, and M and N are different from each other and each represent a metal element selected from the group consisting of Ti, Zr, Sn, Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Al, Si, Cr, Co, Ga, Fe, Mn, Ni, V, Ge, Nb and Ta.
7 . The phosphate adsorbing agent for blood processing according to claim 6 , wherein the metal oxide contains at least one material selected from any of the following groups (a) to (c):
(a) hydrous titanium oxide, hydrous zirconium oxide, hydrous tin oxide, hydrous cerium oxide, hydrous lanthanum oxide and hydrous yttrium oxide, (b) a mixed metal oxide of at least one metal element selected from the group consisting of titanium, zirconium, tin, cerium, lanthanum and yttrium, and at least one metal element selected from the group consisting of aluminum, silicon and iron, and (c) activated alumina.
8 . The phosphate adsorbing agent for blood processing according to claim 1 , wherein the organic polymer resin contains at least one component selected from the group consisting of an ethylene vinyl alcohol copolymer (EVOH), polyacrylonitrile (PAN), polysulfone (PS), polyethersulfone (PES) and polyvinylidene fluoride (PVDF).
9 . A blood processing system comprising a phosphate adsorbing agent for blood processing according to claim 1 .
10 . The blood processing system according to claim 9 , further comprising a blood purifier.
11 . The blood processing system according to claim 10 , wherein the phosphate adsorbing agent for blood processing is disposed such that blood processed by the blood purifier is processed by the phosphate adsorbing agent for blood processing.
12 . The blood processing system according to claim 10 , wherein the phosphate adsorbing agent for blood processing is disposed such that blood processed by the phosphate adsorbing agent for blood processing is processed by the blood purifier.
13 . A blood processing method comprising phosphate adsorption including processing blood using a phosphate adsorbing agent for blood processing according to claim 1 .
14 . The blood processing method according to claim 13 , comprising:
blood purification including processing blood using a blood purifier; and the phosphate adsorption before and/or after the blood purification.
15 . A blood processing method comprising phosphate adsorption including processing blood using a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having the most frequent pore size of 0.08 to 0.70 μm measured with a mercury porosimeter.
16 . The blood processing method according to claim 15 , comprising:
blood purification including processing blood using a blood purifier; and the phosphate adsorption before and/or after the blood purification.Join the waitlist — get patent alerts
Track US2018326136A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.